InsidersTradesSigma
Total declarations
Company
▲ Purchases (11 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Levy Noah G., Director. Officer active across 1 companies, notably Merrimack Pharmaceuticals INC. In total, 11 reports have been logged. Total volume traded: €357k. The latest transaction was filed on 16 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
€1,534297 shares@ €5.16550.4% of flow
Common Stock
SEC:0000899243-22-023332:0·
Ideal exit: 13 Mar 2023 (T+270)
€59,34611,977 shares@ €4.95516.6% of flow
Common Stock
SEC:0000899243-22-022785:0·
Ideal exit: 11 Mar 2023 (T+270)
€16,9273,653 shares@ €4.63374.7% of flow
Common Stock
SEC:0000899243-22-022373:0·
Ideal exit: 7 Mar 2023 (T+270)
€6,0441,505 shares@ €4.01614.3% of flow
Common Stock
SEC:0000899243-22-003837·
Ideal exit: 25 Oct 2022 (T+270)
€6,0441,505 shares@ €4.01611.7% of flow
Common Stock
SEC:0000899243-22-003837:0·
Ideal exit: 25 Oct 2022 (T+270)
€86,50019,528 shares@ €4.429562.0% of flow
Common Stock
SEC:0000899243-22-003553·
Ideal exit: 23 Oct 2022 (T+270)
€86,50019,528 shares@ €4.429524.2% of flow
Common Stock
SEC:0000899243-22-003553:0·
Ideal exit: 23 Oct 2022 (T+270)
€29,4458,719 shares@ €3.377121.1% of flow
Common Stock
SEC:0000899243-22-001744·
Ideal exit: 7 Oct 2022 (T+270)
€29,4458,719 shares@ €3.37718.2% of flow
Common Stock
SEC:0000899243-22-001744:0·
Ideal exit: 7 Oct 2022 (T+270)
€17,6265,215 shares@ €3.379912.6% of flow
Common Stock
SEC:0000899243-22-001470·
Ideal exit: 4 Oct 2022 (T+270)
€17,6265,215 shares@ €3.37994.9% of flow
Common Stock
SEC:0000899243-22-001470:0·
Ideal exit: 4 Oct 2022 (T+270)
11 of 11 declarations
About Levy Noah G.
Noah G. Levy is a Board Member at Merrimack Pharmaceuticals Inc. He participates in strategic decision-making and oversight of the company's operations. With a strong background in the pharmaceutical sector, Levy brings valuable insights to the board, contributing to innovation and growth at Merrimack.
